Skip to main content

ENCAJE PUBLICO-PRIVADO EN SANIDAD: CALIDAD, SOSTENIBILIDAD Y CAMBIOS DEL MODELO ESPAÑOL

ECO2017-83771-C3-2-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Reformas pendientes en la organización de la actividad sanitaria

  • García-Altés, Anna
  • Ortún Rubio, Vicente
Se esquematiza la reciente evolución de la organización sanitaria en España analizando, e ilustrando con ejemplos, la innovación sanitaria. El énfasis del artículo se sitúa en la gestión sanitaria, tanto en la medida de su calidad como en la consideración del impacto de esta calidad en los resultados en salud. Se abordan las limitaciones de la gestión pública, que tanto influyen en las características de la gestión sanitaria, y se recuerda el deterioro institucional relativo de España para plantear las medidas que han de permitir mejorar la calidad de su gobierno. Se concluye con dos escogidas grandes vías de mejora de la gestión sanitaria: la centrada en la financiación pública y las que persiguen hacer individualmente atractivo lo socialmente conveniente., The recent evolution of the healthcare organization in Spain is outlined, analyzing and illustrating with examples, healthcare innovation. The emphasis of the article is placed on healthcare management, both in terms of its quality and in the consideration of the impact of this quality on health outcomes. The limitations of public management, which influence the characteristics of healthcare management, are addressed, and the relative institutional deterioration of Spain is recalled in order to propose the measures that will allow improving the quality of its government. It concludes with two chosen big ways of improvement of healthcare management: the one centered in the public financing and the ones that pursue to make individually attractive what is socially convenient., Vicente Ortún reconoce la financiación del Ministerio de Economía, Industria y Competitividad (Proyecto ECO2017-83771-C3-2-R, Encaje público-privado en sanidad, del Programa Estatal de I+D+i orientada a los retos de la sociedad)., Vicente Ortún reconoce la financiación del Ministerio de Economía, Industria y Competitividad (Proyecto ECO2017-83771-C3-2-R, Encaje público-privado en sanidad, del Programa Estatal de I+D+i orientada a los retos de la sociedad).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Gestió sanitària pública. Disseny de contractes entre administracions públiques i organitzacions sanitàries privades en Espanya

  • Meneu, Ricardo
  • Urbanos Garrido, Rosa María
  • Ortún Rubio, Vicente
Els autors agraeixen el finançament del Ministeri d’Economia, Indústria i Competitivitat (Projecte ECO2017-83771-C3-2-R, Encaje Público-Privado en Sanidad), del Programa Estatal d’R+D+I orientat als reptes de la societat.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: results from three waves of the National Health Survey (2011-2017)

  • Pinilla Domínguez, Jaime
  • Rodriguez-Caro, Alejandro
To compare the differences in the use of healthcare services: visits to the doctor and hospitalisation, performance of routine tests, and preventive influenza vaccination, between users and non-users of homeopathic products. We used the microdata for adults over 15 years old from three waves of the Spanish National Health Survey, corresponding to the years 2011, 2014 and 2017. We proposed a comparative design of a quasi-experimental type, considering as the treatment group the respondents who said that they had used homeopathic products in the past two weeks; and another group, for control, comprising respondents who said that they had not used this type of products, but only conventional medicines, with observable characteristics similar to those of the treatment group. We used a model for rare events logistics regression (relogit) to estimate the probability of using homeopathy. From the propensity score and a vector of control variables, we used techniques of genetic matching to match individuals from the treatment group with similar individuals belonging to the control group. There are no statistically significant differences between users and non-users of homeopathy in visits to the general practitioner (P>|z| 0.387), to the specialist (P>|z| 0.52), in hospitalisations (P>|z| 0.592) or in the use of emergency services (P>|z| 0.109). Nor were there any statistically significant differences in the performance of routine tests, except for the faecal occult blood test, which is more prevalent in users of homeopathic products. 20.9% of users of homeopathy had done this test compared with 15.3% of non-users (P>|z| 0.022). There are also significant differences in vaccination against influenza with 12.6% of homeopathy users stating that they had been vaccinated in the last influenza campaign, against 21.0% of non-users (P>|z| <0.001). The health conditions which homeopathy users reported were constipation (OR: 1.65 CI: 1.16-2.36), malignant tumour (OR: 1.60 CI: 1.09-2.36) osteoporosis (OR: 1.49 CI: 1.05-2.10), varicose veins (OR: 1.35 CI: 1.05-1.74) and allergy (OR: 1.35 CI: 1.06-1.72). Differences in the use of healthcare resources between users and non-users of homeopathic products have not been found to be statistically significant in Spain. It has been shown that most homeopathic products are used as a complement to treatment with conventional medicine. Nevertheless, our results highlight some warning signs which should raise the attention of healthcare authorities. The use of these therapies in patients with malignant tumours and the rejection of vaccines are warning signs of a possible health hazard in the long term., This paper forms part of the research funded by Grant ECO2017-83771-C3-2-R under the ’National Programme for Research, Development and Innovation to Address the Challenges of Society: National Plan for Scientific Research and Technical Innovation 2017–2020' funded by the Ministry of Economy and Competitiveness of Spain. Funder does not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Quality and technical efficiency do not evolve hand in hand in Spanish hospitals: Observational study with administrative data

  • Gorgemans, S.
  • Comendeiro-Maaløe, M.
  • Ridao-López, M.
  • Bernal-Delgado, E.
Objective Recent evidence on the Spanish National Health System (SNHS) reveals a considerable margin for hospital efficiency and quality improvement. However, those studies do not consider both dimensions together. This study aims at jointly studying both technical efficiency (TE) and quality, classifying the public SNHS hospitals according to their joint performance. Methods Stochastic frontier analysis is used to estimate TE and multilevel logistic regressions to build a low-quality composite measure (LQ), which considers in-hospital mortality and safety events. All hospitalizations discharged in Spain in 2003 and 2013, in 179 acute-care general hospitals, were studied. Four scenarios of resulting performance were built setting yearly medians as thresholds for the overall sample, and according to hospital-complexity strata. Results Overall, since 2003, median TE improved and LQ reduced -from TE2003:0.89 to TE2013:0.93 and, from LQ2003:42.6 to LQ2013:27.7 per 1, 000 treated patients. The time estimated coefficient showed technical progress over the period. TE across hospitals showed scarce variability (CV2003:0.08 vs. CV2013:0.07), not so the rates of LQ (CV2003:0.64 vs. CV2013:0.76). No correlation was found between TE values and LQ rates. When jointly considering technical efficiency and quality, hospitals dealing with the highest clinical complexity showed the highest chance to be placed in optimal scenarios, also showing lesser variability between hospitals. Conclusions Efficiency and quality have improved in Spanish public hospitals. Not all hospitals experiencing improvements in efficiency equally improved their quality. The joint analysis of both dimensions allowed identifying those optimal hospitals according to this trade-off.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Evolution of public hospitals expenditure by healthcare area in the Spanish National Health System: the determinants to pay attention to

  • Ridao-Lopez, M.
  • Comendeiro-Maaloe, M.
  • Martinez-Lizaga, N.
  • Bernal-Delgado, E.
Background: In Spain, hospital expenditure represents the biggest share of overall public healthcare expenditure, the most important welfare system directly run by the Autonomous Communities (ACs). Since 2001, public healthcare expenditure has increased well above the GDP growth, and public hospital expenditure increased at an even faster rate. This paper aims at assessing the evolution of need-adjusted public hospital expenditure at healthcare area level (HCA) and its association with utilisation and ''price'' factors, identifying the relative contribution of ACs, as the main locus of health policy decisions. Methods: Ecological study on public hospital expenditure incurred in 198 (HCAs) in 16 Spanish ACs, between 2003 and 2015. Aggregated and annual log-log multilevel models, considering ACs as a cluster, were modelled using administrative data. HCA expenditure was analysed according to differences in population need, utilization and price factors. Standardised coefficients were also estimated, as well as the variance partition coefficients. Results: Between 2003 and 2015, over 59 million hospital episodes were produced in Spain for an overall expenditure of (sic) 384, 200 million. Need-adjusted public hospital expenditure, at HCA level, was mainly associated to medical and surgical hospitalizations (standardized coefficients 0.32 and 0.28, respectively). The ACs explained 42% of the variance not explained by HCA utilization and ''price'' factors. Conclusions: Utilization, rather than ''price'' factors, may be explaining the difference in need-adjusted public hospital expenditure at HCA level in Spain. ACs, third-payers in the fully devolved Spanish National Health System, are responsible for a great deal of the variation in hospital expenditure.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A comparative performance analysis of a renowned public private partnership for health care provision in Spain between 2003 and 2015

  • Comendeiro-Maaløe, M.
  • Ridao-López, M.
  • Gorgemans, S.
  • Bernal-Delgado, E.
Background: Recently, the once archetype of the public private partnership (PPP) in the Spanish National Health System (SNHS), namely the Alzira's Model, has come to an end. Advocates defended the superiority of PPPs over public-tenured provision, in terms of quality and technical efficiency. This paper profiles and compares Alzira's life-cycle performance with similar public-tenured providers. Methods: Observational study on secondary data from virtually all hospital care episodes produced in 51 integrated providers (i.e., administrative healthcare areas) and 67 hospitals, in 2003 and 2015. Alzira's 2015 performance (and its variation since 2003) was compared with all public-tenured peers in the SNHS, using 26 indicators analysing the differences in age-sex standardized rates of events or risk-adjusted mortality, severity-adjusted hospital expenditure and hospital technical efficiency. Results: In comparison with the corresponding public-tenured peers, Alzira's 2015 performance was statistically worse than the benchmark in the majority of indicators (15 out of 26); yet, its performance was one of the best in the SNHS in adjusted-mortality after Percutaneous Coronary Intervention (PCI). Over time, Alzira showed a statistically greater 2003–2015 improvement than its peers’ average in eleven of the indicators, and a lower improvement in nine. Conclusions: In this comprehensive comparative study on Alzira''s performance, this PPP has not generally outperformed public-tenured providers, although in some areas of care its developments have been outstanding.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differences in healthcare utilisation between users and non-users of homeopathic products in Spain: results from three waves of the National Health Survey (2011-2017)

  • Pinilla Domínguez, Jaime
  • Rodriguez-Caro, Alejandro
To compare the differences in the use of healthcare services: visits to the doctor and hospitalisation, performance of routine tests, and preventive influenza vaccination, between users and non-users of homeopathic products. We used the microdata for adults over 15 years old from three waves of the Spanish National Health Survey, corresponding to the years 2011, 2014 and 2017. We proposed a comparative design of a quasi-experimental type, considering as the treatment group the respondents who said that they had used homeopathic products in the past two weeks; and another group, for control, comprising respondents who said that they had not used this type of products, but only conventional medicines, with observable characteristics similar to those of the treatment group. We used a model for rare events logistics regression (relogit) to estimate the probability of using homeopathy. From the propensity score and a vector of control variables, we used techniques of genetic matching to match individuals from the treatment group with similar individuals belonging to the control group. There are no statistically significant differences between users and non-users of homeopathy in visits to the general practitioner (P>|z| 0.387), to the specialist (P>|z| 0.52), in hospitalisations (P>|z| 0.592) or in the use of emergency services (P>|z| 0.109). Nor were there any statistically significant differences in the performance of routine tests, except for the faecal occult blood test, which is more prevalent in users of homeopathic products. 20.9% of users of homeopathy had done this test compared with 15.3% of non-users (P>|z| 0.022). There are also significant differences in vaccination against influenza with 12.6% of homeopathy users stating that they had been vaccinated in the last influenza campaign, against 21.0% of non-users (P>|z| <0.001). The health conditions which homeopathy users reported were constipation (OR: 1.65 CI: 1.16-2.36), malignant tumour (OR: 1.60 CI: 1.09-2.36) osteoporosis (OR: 1.49 CI: 1.05-2.10), varicose veins (OR: 1.35 CI: 1.05-1.74) and allergy (OR: 1.35 CI: 1.06-1.72). Differences in the use of healthcare resources between users and non-users of homeopathic products have not been found to be statistically significant in Spain. It has been shown that most homeopathic products are used as a complement to treatment with conventional medicine. Nevertheless, our results highlight some warning signs which should raise the attention of healthcare authorities. The use of these therapies in patients with malignant tumours and the rejection of vaccines are warning signs of a possible health hazard in the long term., This paper forms part of the research funded by Grant ECO2017-83771-C3-2-R under the ’National Programme for Research, Development and Innovation to Address the Challenges of Society: National Plan for Scientific Research and Technical Innovation 2017–2020' funded by the Ministry of Economy and Competitiveness of Spain. Funder does not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

How do consumers respond to “sin taxes”? New evidence from a tax on sugary drinks

  • Fichera, Eleonora
  • Mora, Toni
  • G Lopez-Valcarcel, Beatriz
  • Roche, David
We thank participants of the European Society for Population Economics (2019); the International Health Economics Association precongress organized session on the Economics of Obesity (2019); the Health Economists’ Study Group at the University of York (2018); the American Society of Health Economists conference in Atlanta (2018); seminar participants at the Department of Economics, University of Leicester and University of Bath, Public Health England (London), the Health Economics Group at the University of Newcastle and the Health Economics Research Centre at the University of Oxford. Authors gratefully acknowledge the financial support received from the Chair in Public Finance: Healthcare and Education Policy Assessment (cooperation with EUREST Catalunya). Financial support was also received from the ECO2017-83771-C3-3-R (MINECO/AEI/FEDER, UE) and 2017SGR263 and marketing department of the supermarket chain., It is unclear what the effects of taxes on sugar sweetened beverages (SSBs) are on consumer behaviour and which consumers may be affected the most. We evaluate the effect of the SSB tax introduced in Catalonia (but not in the rest of Spain) in May 2017 using loyalty card data of monthly purchases by 884,843 households from May 2016 to April 2018. Using a Difference-in-Differences approach, we study the SSB tax effect on the purchased quantity of beverages and sugar. Our results suggest a reduction in purchases of taxed beverages and a small increase in purchases of untaxed beverages. Households have substituted taxed beverages with their lower sugar (untaxed) counterparts. This has led to a 2.2% overall reduction in sugar purchases from beverages. Our study implies that although sin taxes moderately change consumer behaviour, a combination of different policies would be required to tackle obesity., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gestió sanitària pública. Disseny de contractes entre administracions públiques i organitzacions sanitàries privades en Espanya

  • Meneu, Ricardo
  • Urbanos Garrido, Rosa María
  • Ortún Rubio, Vicente
Els autors agraeixen el finançament del Ministeri d’Economia, Indústria i Competitivitat (Projecte ECO2017-83771-C3-2-R, Encaje Público-Privado en Sanidad), del Programa Estatal d’R+D+I orientat als reptes de la societat.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gender differences in labour losses associated with smoking-related mortality

  • Oliva Moreno, Juan
  • Trapero Bertran, Marta
  • Peña-Longobardo, Luz María
This research forms part of the research funded by Grant ECO2017-83771-C3-2-R under the National Programme for Research, Development and Innovation to Address the Challenges of Society: National Plan for Scientific Research and Technical Innovation 2017–2020, funded by the Ministry of Economy and Competitiveness of Spain. The funder did not play any role in the study design, data collection or analysis, decision to publish or preparation of the manuscript., The aim of this paper was to estimate the number of premature deaths, years of potential productive life lost (YPPLL) and labour losses attributable to tobacco smoking due to premature death by gender for the Spanish population. The human capital approach was applied. Employment, gross wage and death data were obtained from the Spanish National Institute of Statistics. Relative risks of death due to cigarette smoking and former smoking were applied. The base case used an annual discount rate of 3% and an annual labour productivity growth rate of 1%. Univariate deterministic sensitivity analysis was performed on discount rates and labour productivity growth rates. Between 2002 and 2016, smoking was estimated to cause around 13,171–13,781 annual deaths in the population under 65 years of age (legal retirement age) in Spain. This increase was mostly due to female deaths. YPPLLs for females have increased over the years, while for males they have fallen markedly. Labour losses associated with smoking mortality ranged from €2269 million in 2002 to €1541 in 2016 (base year 2016). In fact, labour productivity losses have decreased over the years for men (−39.8%) but increased sharply for women (101.6%). The evolution of monetary value of lost productivity due to smoking mortality shows clearly differentiated trends by gender. View Full-Text, info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Reformas pendientes en la organización de la actividad sanitaria

  • García-Altés, Anna
  • Ortún Rubio, Vicente
Se esquematiza la reciente evolución de la organización sanitaria en España analizando, e ilustrando con ejemplos, la innovación sanitaria. El énfasis del artículo se sitúa en la gestión sanitaria, tanto en la medida de su calidad como en la consideración del impacto de esta calidad en los resultados en salud. Se abordan las limitaciones de la gestión pública, que tanto influyen en las características de la gestión sanitaria, y se recuerda el deterioro institucional relativo de España para plantear las medidas que han de permitir mejorar la calidad de su gobierno. Se concluye con dos escogidas grandes vías de mejora de la gestión sanitaria: la centrada en la financiación pública y las que persiguen hacer individualmente atractivo lo socialmente conveniente., The recent evolution of the healthcare organization in Spain is outlined, analyzing and illustrating with examples, healthcare innovation. The emphasis of the article is placed on healthcare management, both in terms of its quality and in the consideration of the impact of this quality on health outcomes. The limitations of public management, which influence the characteristics of healthcare management, are addressed, and the relative institutional deterioration of Spain is recalled in order to propose the measures that will allow improving the quality of its government. It concludes with two chosen big ways of improvement of healthcare management: the one centered in the public financing and the ones that pursue to make individually attractive what is socially convenient., Vicente Ortún reconoce la financiación del Ministerio de Economía, Industria y Competitividad (Proyecto ECO2017-83771-C3-2-R, Encaje público-privado en sanidad, del Programa Estatal de I+D+i orientada a los retos de la sociedad)., Vicente Ortún reconoce la financiación del Ministerio de Economía, Industria y Competitividad (Proyecto ECO2017-83771-C3-2-R, Encaje público-privado en sanidad, del Programa Estatal de I+D+i orientada a los retos de la sociedad).